Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company s first pipeline product, the DenerveX System, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options. To learn more about Medovex Corp., visit www.medovex.com.
Quote | Medovex Corp (OTCMKTS:MDVX)
Last: | $ |
---|---|
Change Percent: | 4.55% |
Open: | $0.40 |
Close: | $0.4025 |
High: | $0.4025 |
Low: | $0.39 |
Volume: | 8,750 |
Last Trade Date Time: | 07/12/2019 04:56:39 pm |
News | Medovex Corp (OTCMKTS:MDVX)
TAMPA, Fla., July 12, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today announced that FINRA has approved the effectiveness of a change in the company’s name from “Medovex Corp.” to “H-CYTE, Inc.” as well as a change in the Company’s tradi...
TAMPA, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today updated investors on its name change and rebranding to H-CYTE. The announcement underscores the Company's broader commitment focusing on delivering regenerative anti-inflammatory solutions to treat the unmet n...
Message Board Posts | Medovex Corp (OTCMKTS:MDVX)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Medovex Corp Company Name:
MDVX Stock Symbol:
OTCMKTS Market:
TAMPA, Fla., July 12, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today announced that FINRA has approved the effectiveness of a change in the company’s name from “Medovex Corp.” to “H-CYTE, Inc.” as well as a change in the Company’s tradi...
TAMPA, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today updated investors on its name change and rebranding to H-CYTE. The announcement underscores the Company's broader commitment focusing on delivering regenerative anti-inflammatory solutions to treat the unmet n...
TAMPA, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today updated investors on its name change and rebranding to H-CYTE. The announcement underscores the Company's broader commitment focusing on delivering regenerative anti-inflammatory solutions to treat the unmet n...